Reducing the Burden of Cytomegalovirus in HCT: Optimal Strategy Selection for Prevention

Expert insights for APPs from Dr Roy Chemaly on the latest clinically relevant data on the prevention and management of cytomegalovirus (CMV) infection in the setting of hematopoietic cell transplant.

Share

Program Content

Activities

Optimal Strategy for CMV Prevention in HCT
Reducing the Burden of Cytomegalovirus in HCT: Optimal Strategy for Prevention
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: July 21, 2023

Expires: July 20, 2024

Faculty

cover img faculity

Roy F. Chemaly, MD, MPH

Professor of Medicine
Department of Infectious Diseases, Infection Control, and Employee Health
The University of Texas MD Anderson Cancer Center
Houston, Texas

Provided by

ProCE Banner

Provided by Partners for Advancing Clinical Education (PACE)

Supporters

This activity is supported by an educational grant from Merck Sharp & Dohme LLC.

Merck Sharp & Dohme, LLC